Nitazoxanide for severe cryptosporidial diarrhea in human immunodeficiency virus infected children

dc.contributor.authorAbraham, D. R.
dc.contributor.authorRabie, H.
dc.contributor.authorCotton, M. F.
dc.date.accessioned2011-05-15T16:00:06Z
dc.date.available2011-05-15T16:00:06Z
dc.date.issued2008
dc.description.abstract[No abstract available]
dc.description.versionLetter
dc.identifier.citationPediatric Infectious Disease Journal
dc.identifier.citation27
dc.identifier.citation11
dc.identifier.issn8913668
dc.identifier.other10.1097/INF.0b013e318186257b
dc.identifier.urihttp://hdl.handle.net/10019.1/11529
dc.subjectantiretrovirus agent
dc.subjectcotrimoxazole
dc.subjectlamivudine
dc.subjectlopinavir plus ritonavir
dc.subjectmetronidazole
dc.subjectnitazoxanide
dc.subjectritonavir
dc.subjectstavudine
dc.subjectcoccidiostatic agent
dc.subjectthiazole derivative
dc.subjectcase report
dc.subjectchild
dc.subjectclinical feature
dc.subjectClostridium difficile infection
dc.subjectcryptosporidiosis
dc.subjectCryptosporidium parvum
dc.subjectdiarrhea
dc.subjectdrug effect
dc.subjectdrug efficacy
dc.subjectgiardiasis
dc.subjecthuman
dc.subjectHuman immunodeficiency virus infected patient
dc.subjectHuman immunodeficiency virus infection
dc.subjectinfant
dc.subjectletter
dc.subjectpreschool child
dc.subjectpriority journal
dc.subjectAIDS related complex
dc.subjectanimal
dc.subjectclinical trial
dc.subjectcontrolled clinical trial
dc.subjectcontrolled study
dc.subjectrandomized controlled trial
dc.subjectAIDS-Related Opportunistic Infections
dc.subjectAnimals
dc.subjectChild, Preschool
dc.subjectCoccidiostats
dc.subjectCryptosporidiosis
dc.subjectCryptosporidium parvum
dc.subjectDiarrhea
dc.subjectHumans
dc.subjectInfant
dc.subjectThiazoles
dc.titleNitazoxanide for severe cryptosporidial diarrhea in human immunodeficiency virus infected children
dc.typeLetter
Files